A open-lable,single arm and exploratory clinical trail of Apatinib for first-line Maintenance treatment of advanced colorectal cancer.
Phase of Trial: Phase IV
Latest Information Update: 19 Sep 2017
At a glance
- Drugs Rivoceranib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 19 Sep 2017 New trial record